المؤلفون: Harpreet Singh, Christian H. Ottensmeier, Judith R. Kroep, Michael Platten, Andreas von Deimling, Juan Sahuquillo, Eilon Barnea, Cedrik M. Britten, Francisco Martínez-Ricarte, Sebastian Kreiter, Itzhak Rosner, Ghazaleh Tabatabai, Wolfgang Wick, Gleb Slobodin, Hans Skovgaard Poulsen, Sabrina Kuttruff, Sjoerd H. van der Burg, Per thor Straten, Marcos Tatagiba, Dganit Melamed Kadosh, Norbert Hilf, Colette Song, Hans-Georg Rammensee, Frank Winkler, Valérie Dutoit, Ulrik Lassen, Arie Admon, Katrin Frenzel, Pierre-Yves Dietrich, Yael Haimovich, Hideho Okada, Ugur Sahin, Berta Ponsati, Jordi Rodon, John C. Castle, Carlos López-Larrea, Bracha Shraibman

المصدر: Molecular and Cellular Proteomics
Molecular & cellular proteomics : MCP, vol 18, iss 6
Mol Cell Proteomics
Molecular and Cellular Proteomics, Vol. 17, No 11 (2018) pp. 2132-2145
Molecular and Cellular Proteomics, Vol. 18, No 6 (2019) pp. 1255-1268
Molecular and Cellular Proteomics, 17(11), 2132-2145

مصطلحات موضوعية: 0301 basic medicine, Proteome, medicine.medical_treatment, MHC - major histocompatibility complex, HLA - human leukocytes antigen, Immunoaffinity, Biochemistry, Analytical Chemistry, Cancer Biomarker(s), 0302 clinical medicine, HLA Antigens, Medicine, Withdrawals/Retractions, Peptidomics, Cancer, ddc:616, 0303 health sciences, Tumor, medicine.diagnostic_test, Brain Neoplasms, CTA - cancer/testis antigens, 3. Good health, HLA, 030220 oncology & carcinogenesis, CTA (Cancer/Testis Antigens), Immunotherapy, HLA (Human Leukocytes Antigen), Biochemistry & Molecular Biology, Immunology, Brain tumor, Plasma or Serum Analysis, Human leukocyte antigen, Cancer Therapeutics, 03 medical and health sciences, Rare Diseases, Antigen, Antigens, Neoplasm, Clinical Research, Biomarkers, Tumor, Humans, Blood test, Amino Acid Sequence, Antigens, Gene, Molecular Biology, Alleles, 030304 developmental biology, MHC (Major Histocompatibility Complex), CTA, business.industry, Research, Cell Membrane, Histocompatibility Antigens Class I, Neurosciences, medicine.disease, Brain Disorders, Brain Cancer, Good Health and Well Being, 030104 developmental biology, Solubility, Cancer research, Neoplasm, MHC, Glioblastoma, Peptides, business, Biomarkers

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7952a7688b32f085d344d25a5212ed3
https://doi.org/10.1074/mcp.ra119.001524

المؤلفون: Anja Smits, Anna Wenger, Helena Carén, Fredrik B. Thorén, Alexander Hallner, Katja Werlenius, Asgeir Store Jakola, Bertil Rydenhag, Magnus Tisell, Dan Farahmand

المصدر: Neoplasia
Neoplasia (New York, N.Y.)
Neoplasia: An International Journal for Oncology Research, Vol 20, Iss 1, Pp 25-31 (2018)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Adoptive cell transfer, medicine.medical_treatment, GBM, Glioblastoma, Immunotherapy, Adoptive, 0302 clinical medicine, T-Lymphocyte Subsets, Cytotoxic T cell, Th cells, T helper cells, Brain Neoplasms, Basic Medicine, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Combined Modality Therapy, 030220 oncology & carcinogenesis, Neoplastic Stem Cells, Cancer/testis antigens, Female, SOX2, SRY (sex determining region Y)-box 2, Stem cell, CTL, Cytotoxic T lymphocytes, medicine.drug, CTA, Cancer/testis antigens, Adult, medicine.medical_specialty, Original article, Medicinska och farmaceutiska grundvetenskaper, lcsh:RC254-282, CSC, Cancer stem cells, HGG, High-grade glioma, 03 medical and health sciences, ALECSAT, Autologous Lymphoid Effector Cells Specific Against Tumor Cells, Cancer stem cell, Internal medicine, Cell Line, Tumor, medicine, Humans, Lymphocyte Count, Aged, MHC, Major histocompatibility complex, PCA, Principal component analysis, Temozolomide, business.industry, Immunotherapy, Fibroblasts, NK cells, Natural killer cells, 030104 developmental biology, ALECSAT, TMZ, Temozolomide, FBS, Fetal bovine serum, Treg cells, T regulatory cells, Radiotherapy, Adjuvant, business, Glioblastoma

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ed6d1c5f25eaba56d11b34bb2a70e8e
https://hdl.handle.net/11250/3045011

المصدر: DTIC

مصطلحات الفهرس: Medicine and Medical Research, PROSTATE CANCER, ANTIGENS, CELLS(BIOLOGY), GENES, METASTASIS, SPANXB2, STROMAS, CTA(CANCER TESTIS ANTIGENS), Text

URL: https://apps.dtic.mil/docs/citations/ADA612613

المؤلفون: Shraibman B; From the ‡Department of Biology, Technion, Israel Institute of Technology, Haifa 32000, Israel., Barnea E; From the ‡Department of Biology, Technion, Israel Institute of Technology, Haifa 32000, Israel., Kadosh DM; From the ‡Department of Biology, Technion, Israel Institute of Technology, Haifa 32000, Israel., Haimovich Y; From the ‡Department of Biology, Technion, Israel Institute of Technology, Haifa 32000, Israel., Slobodin G; §Rheumatology Unit, Bnai Zion Medical Center, Haifa 31048, Israel., Rosner I; §Rheumatology Unit, Bnai Zion Medical Center, Haifa 31048, Israel., López-Larrea C; ¶Hospital Universitario Central de Asturias, 33011 Oviedo, Asturias, Spain., Hilf N; ‖Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15,72076 Tuebingen, Germany., Kuttruff S; ‖Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15,72076 Tuebingen, Germany., Song C; ‖Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15,72076 Tuebingen, Germany., Britten C; *BioNTech AG, Holderlinstr. 8,55131 Mainz, Germany.; ¶¶¶Association for Cancer Immunotherapy (CIMT), Langenbeckstr. 1,55131 Mainz, Germany., Castle J; *BioNTech AG, Holderlinstr. 8,55131 Mainz, Germany., Kreiter S; *BioNTech AG, Holderlinstr. 8,55131 Mainz, Germany., Frenzel K; *BioNTech AG, Holderlinstr. 8,55131 Mainz, Germany., Tatagiba M; ‡‡Eberhard Karls Universität Tübingen, Department of Immunology, Auf der Morgenstelle 15,72076 Tubingen, Germany., Tabatabai G; ‡‡Eberhard Karls Universität Tübingen, Department of Immunology, Auf der Morgenstelle 15,72076 Tubingen, Germany., Dietrich PY; §§Université de Genève, Rue Gabrielle Perret Gentil 4; 1211 Geneve 14, Switzerland., Dutoit V; §§Université de Genève, Rue Gabrielle Perret Gentil 4; 1211 Geneve 14, Switzerland., Wick W; ¶¶Heidelberg University Medical Center, Im Neuenheimer Feld 672, D-69120 Heidelberg, Germany., Platten M; ¶¶Heidelberg University Medical Center, Im Neuenheimer Feld 672, D-69120 Heidelberg, Germany., Winkler F; ¶¶Heidelberg University Medical Center, Im Neuenheimer Feld 672, D-69120 Heidelberg, Germany., von Deimling A; ¶¶Heidelberg University Medical Center, Im Neuenheimer Feld 672, D-69120 Heidelberg, Germany., Kroep J; ‖‖Leiden University Medical Center, Department of Medical Oncology, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Sahuquillo J; ‡‡‡Vall d'Hebron University Hospital, Institut Catala de la Salut, Pg. Vall d'Hebron 119-129, 08035 Barcelona, Spain., Martinez-Ricarte F; ‡‡‡Vall d'Hebron University Hospital, Institut Catala de la Salut, Pg. Vall d'Hebron 119-129, 08035 Barcelona, Spain., Rodon J; ‡‡‡Vall d'Hebron University Hospital, Institut Catala de la Salut, Pg. Vall d'Hebron 119-129, 08035 Barcelona, Spain., Lassen U; ‖‖‖Region Hovedstaden (Center for Cancer Immune Therapy (CCIT), Herlev Hospital, Herlev Ringvej 75, DK-2730, Copenhagen, Denmark., Ottensmeier C; §§§Cancer Sciences Division, Faculty of Medicine, University of Southampton, Southampton, UK., van der Burg SH; ‖‖Leiden University Medical Center, Department of Medical Oncology, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; ¶¶¶Association for Cancer Immunotherapy (CIMT), Langenbeckstr. 1,55131 Mainz, Germany., Thor Straten P; ‖‖‖Region Hovedstaden (Center for Cancer Immune Therapy (CCIT), Herlev Hospital, Herlev Ringvej 75, DK-2730, Copenhagen, Denmark., Poulsen HS; ‡‡‡‡Rigshospitalet, Departments of Radiation Biology and Oncology, Rigshospitalet 9, Blegdamsvej, DK-2100, Copenhagen, Denmark., Ponsati B; §§§§BCN Peptides, Pol. Ind. Els Vinyets-Els Fogars II. 08777 Sant Quinti de Mediona (Barcelona), Spain., Okada H; ¶¶¶¶University of California and the Parker Institute for Cancer Immunotherapy, San Francisco, CA 94131., Rammensee HG; ‡‡Eberhard Karls Universität Tübingen, Department of Immunology, Auf der Morgenstelle 15,72076 Tubingen, Germany., Sahin U; *BioNTech AG, Holderlinstr. 8,55131 Mainz, Germany., Singh H; ‖Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15,72076 Tuebingen, Germany., Admon A; From the ‡Department of Biology, Technion, Israel Institute of Technology, Haifa 32000, Israel; admon@technion.ac.il.

المصدر: Molecular & cellular proteomics : MCP [Mol Cell Proteomics] 2019 Jun; Vol. 18 (6), pp. 1255-1268.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 101125647 Publication Model: Print Cited Medium: Internet ISSN: 1535-9484 (Electronic) Linking ISSN: 15359476 NLM ISO Abbreviation: Mol Cell Proteomics Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, Neoplasm/*blood , Brain Neoplasms/*blood , Glioblastoma/*blood , Histocompatibility Antigens Class I/*blood , Peptides/*blood , Proteome/*metabolism, Alleles ; Biomarkers, Tumor/blood ; Brain Neoplasms/surgery ; Glioblastoma/surgery ; Humans

المؤلفون: Shraibman B; From the ‡Biology, Technion - Israel Institute of Technology, Haifa 32000, Israel., Barnea E; From the ‡Biology, Technion - Israel Institute of Technology, Haifa 32000, Israel., Kadosh DM; From the ‡Biology, Technion - Israel Institute of Technology, Haifa 32000, Israel., Haimovich Y; From the ‡Biology, Technion - Israel Institute of Technology, Haifa 32000, Israel., Slobodin G; §Rheumatology Unit Bnai Zion Medical Center, Haifa 31048, Israel., Rosner I; §Rheumatology Unit Bnai Zion Medical Center, Haifa 31048, Israel., López-Larrea C; ¶Hospital Universitario Central de Asturias, 33011 Oviedo, Asturias, Spain., Hilf N; ‖Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15,72076 Tuebingen, Germany., Kuttruff S; ‖Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15,72076 Tuebingen, Germany., Song C; ‖Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15,72076 Tuebingen, Germany., Britten C; *BioNTech AG, Holderlinstr. 8,55131 Mainz, Germany.; ¶¶¶Association for Cancer Immunotherapy (CIMT), Langenbeckstr. 1,55131 Mainz, Germany., Castle J; *BioNTech AG, Holderlinstr. 8,55131 Mainz, Germany., Kreiter S; *BioNTech AG, Holderlinstr. 8,55131 Mainz, Germany., Frenzel K; *BioNTech AG, Holderlinstr. 8,55131 Mainz, Germany., Tatagiba M; ‡‡Eberhard Karls Universität Tübingen, Department of Immunology, Auf der Morgenstelle 15,72076 Tubingen, Germany., Tabatabai G; ‡‡Eberhard Karls Universität Tübingen, Department of Immunology, Auf der Morgenstelle 15,72076 Tubingen, Germany., Dietrich PY; §§Université de Genève, Rue Gabrielle Perret Gentil 4; 1211 Geneve 14, Switzerland., Dutoit V; §§Université de Genève, Rue Gabrielle Perret Gentil 4; 1211 Geneve 14, Switzerland., Wick W; ¶¶Heidelberg University Medical Center, Im Neuenheimer Feld 672, D-69120 Heidelberg, Germany., Platten M; ¶¶Heidelberg University Medical Center, Im Neuenheimer Feld 672, D-69120 Heidelberg, Germany., Winkler F; ¶¶Heidelberg University Medical Center, Im Neuenheimer Feld 672, D-69120 Heidelberg, Germany., von Deimling A; ¶¶Heidelberg University Medical Center, Im Neuenheimer Feld 672, D-69120 Heidelberg, Germany., Kroep J; ‖‖Leiden University Medical Center, Department of Medical Oncology, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Sahuquillo J; **Vall d'Hebron University Hospital, Institut Catala de la Salut, Pg. Vall d'Hebron 119-129, 08035 Barcelona, Spain., Martinez-Ricarte F; **Vall d'Hebron University Hospital, Institut Catala de la Salut, Pg. Vall d'Hebron 119-129, 08035 Barcelona, Spain., Rodon J; **Vall d'Hebron University Hospital, Institut Catala de la Salut, Pg. Vall d'Hebron 119-129, 08035 Barcelona, Spain., Lassen U; ‡‡‡Region Hovedstaden (Center for Cancer Immune Therapy (CCIT), Herlev Hospital, Herlev Ringvej 75, DK-2730, Copenhagen, Denmark., Ottensmeier C; §§§Cancer Sciences Division, Faculty of Medicine, University of Southampton, Southampton, UK., van der Burg SH; ‖‖Leiden University Medical Center, Department of Medical Oncology, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; ¶¶¶Association for Cancer Immunotherapy (CIMT), Langenbeckstr. 1,55131 Mainz, Germany., Thor Straten P; ‡‡‡Region Hovedstaden (Center for Cancer Immune Therapy (CCIT), Herlev Hospital, Herlev Ringvej 75, DK-2730, Copenhagen, Denmark., Poulsen HS; ‖‖‖Rigshospitalet, Departments of Radiation Biology and Oncology, Rigshospitalet 9, Blegdamsvej, DK-2100, Copenhagen, Denmark., Ponsati B; ***BCN Peptides, Pol. Ind. Els Vinyets-Els Fogars II. 08777 Sant Quinti de Mediona (Barcelona), Spain., Okada H; ‡‡‡‡University of California, San Francisco, CA 94131 USA., Rammensee HG; ‡‡Eberhard Karls Universität Tübingen, Department of Immunology, Auf der Morgenstelle 15,72076 Tubingen, Germany., Sahin U; *BioNTech AG, Holderlinstr. 8,55131 Mainz, Germany., Singh H; ‖Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15,72076 Tuebingen, Germany., Admon A; From the ‡Biology, Technion - Israel Institute of Technology, Haifa 32000, Israel; admon@technion.ac.il.

المصدر: Molecular & cellular proteomics : MCP [Mol Cell Proteomics] 2018 Nov; Vol. 17 (11), pp. 2132-2145. Date of Electronic Publication: 2018 Aug 02.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication

بيانات الدورية: Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 101125647 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-9484 (Electronic) Linking ISSN: 15359476 NLM ISO Abbreviation: Mol Cell Proteomics Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, Neoplasm/*blood , Glioblastoma/*blood , HLA Antigens/*metabolism , Peptides/*metabolism , Proteome/*metabolism, Alleles ; Amino Acid Sequence ; Antigens, Neoplasm/metabolism ; Biomarkers, Tumor/blood ; Cell Membrane/metabolism ; Glioblastoma/surgery ; Humans ; Peptides/blood ; Peptides/chemistry ; Solubility

المصدر: DTIC

مصطلحات الفهرس: Biochemistry, Genetic Engineering and Molecular Biology, Anatomy and Physiology, Medicine and Medical Research, ANTIGENS, GENE EXPRESSION, PROSTATE CANCER, PROTEINS, ASSAYING, GENES, METASTASIS, RIBONUCLEIC ACIDS, BIOMARKERS, PHENOTYPES, CTA(CANCER TESTIS ANTIGENS), RP(RADICAL PROSTATECTOMY), PCA(PROSTATE CANCER), NANOSTRING NCOUNTER ANALYSIS, CTA GENES, Text

URL: https://apps.dtic.mil/docs/citations/ADA590492